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We have erroneously used the untransformed values for hemoglobin in the article (Fig. 1). The ﬁgure states that the values are g/dL, but
the values are mmol/L. The hemoglobin values should therefore be multiplied by a transformation factor of 1,61. Please see the new ﬁgure
with transformed values.
The authors would like to apologise for any inconvenience.
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